BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22417659)

  • 21. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
    Kim JS; Okamoto K; Rubin BK
    Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
    Daviskas E; Anderson SD; Young IH
    Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis.
    Stelmach I; Korzeniewska A; Stelmach W; Majak P; Grzelewski T; Jerzynska J
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):372-80. PubMed ID: 16279568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic.
    Radhakrishnan DK; Corey M; Dell SD
    Arch Pediatr Adolesc Med; 2007 Jun; 161(6):603-6. PubMed ID: 17548767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.
    Dwyer TJ; Zainuldin R; Daviskas E; Bye PT; Alison JA
    BMC Pulm Med; 2017 Jan; 17(1):14. PubMed ID: 28077104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B; King M
    Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive clearance of airway secretions.
    Hardy KA; Anderson BD
    Respir Care Clin N Am; 1996 Jun; 2(2):323-45. PubMed ID: 9390886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.
    Radtke T; Böni L; Bohnacker P; Maggi-Beba M; Fischer P; Kriemler S; Benden C; Dressel H
    BMC Pulm Med; 2018 Jun; 18(1):99. PubMed ID: 29898704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
    Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
    Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.
    Konstan MW; Stern RC; Doershuk CF
    J Pediatr; 1994 May; 124(5 Pt 1):689-93. PubMed ID: 8176554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity.
    Hasani A; Pavia D; Agnew JE; Clarke SW
    Thorax; 1994 Jun; 49(6):557-61. PubMed ID: 8016793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
    Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
    Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
    Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
    Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise with incorporated expiratory manoeuvres was as effective as breathing techniques for airway clearance in children with cystic fibrosis: a randomised crossover trial.
    Reix P; Aubert F; Werck-Gallois MC; Toutain A; Mazzocchi C; Moreux N; Bellon G; Rabilloud M; Kassai B
    J Physiother; 2012; 58(4):241-7. PubMed ID: 23177226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.
    Sagel SD; Kapsner R; Osberg I; Sontag MK; Accurso FJ
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1425-31. PubMed ID: 11704590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of intrapulmonary percussive ventilation and chest physiotherapy. A pilot study in patients with cystic fibrosis.
    Natale JE; Pfeifle J; Homnick DN
    Chest; 1994 Jun; 105(6):1789-93. PubMed ID: 8205878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
    Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
    Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.